ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
C14orf105 | Chromosome 14 open reading frame 105 | | | | | | Group enriched |
CUX2 | Cut-like homeobox 2 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like | Transcription factors
| | | | | Group enriched |
HFE2 | Hemochromatosis type 2 (juvenile) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes
| | | | | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GLYATL1 | Glycine-N-acyltransferase-like 1 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
PIPOX | Pipecolic acid oxidase | Enzymes Plasma proteins
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
UGT2B11 | UDP glucuronosyltransferase 2 family, polypeptide B11 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
C8G | Complement component 8, gamma polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CLDN14 | Claudin 14 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Group enriched |
ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | Enzymes
| | | | | Group enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
TBX15 | T-box 15 | Disease related genes Transcription factors
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
FCN3 | Ficolin (collagen/fibrinogen domain containing) 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
HRSP12 | Heat-responsive protein 12 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KDM8 | Lysine (K)-specific demethylase 8 | Enzymes
| | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
RIPPLY1 | Ripply transcriptional repressor 1 | Predicted secreted proteins
| | | | | Group enriched |
SEC14L4 | SEC14-like 4 (S. cerevisiae) | | | | | | Group enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATF5 | Activating transcription factor 5 | Transcription factors
| | | | | Group enriched |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GCKR | Glucokinase (hexokinase 4) regulator | | | | | | Group enriched |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
SLC25A18 | Solute carrier family 25 (glutamate carrier), member 18 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
UGT2B7 | UDP glucuronosyltransferase 2 family, polypeptide B7 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
GLYAT | Glycine-N-acyltransferase | Enzymes Mitochondrial proteins
| | | | | Group enriched |
GOLT1A | Golgi transport 1A | Predicted membrane proteins
| | | | | Group enriched |
IGSF23 | Immunoglobulin superfamily, member 23 | Predicted membrane proteins
| | | | | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes
| | | | | Group enriched |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
ACOT6 | Acyl-CoA thioesterase 6 | | | | | | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |